stella
beta
Blood Donor CVD 5000 — Stella
Recruiting
Back to Risk Reduction trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
United States
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland
View full record on ClinicalTrials.gov